|
|
|
||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | |||||
First published online July 2, 2007
doi: 10.1242/10.1242/jcs.007963
Research Article |
Department of Genetics and Tumor Cell Biology, St Jude Children's Research Hospital, 332 N. Lauderdale, Memphis, TN 38105, USA
* Author for correspondence (e-mail: Jill.Lahti{at}stjude.org)
Accepted 15 May 2007
| Summary |
|---|
|
|
|---|
Key words: CDK11p58, Cell cycle, Mitosis, Cyclin-dependent kinase, Sister chromatid cohesion, Cohesin, Mouse
| Introduction |
|---|
|
|
|---|
Sister chromatid cohesion is mediated by the cohesin complex. Establishment of chromosome cohesion occurs during DNA synthesis in S phase, and the association of paired sister chromatids must be maintained until anaphase to ensure accurate chromosome segregation. Chromosome arm cohesin is removed during prophase and prometaphase through a nonproteolytic process that requires Plk1 and aurora B kinase activity. Plk1 can phosphorylate the cohesin subunits Scc1 and SA2 in vitro, and the phosphorylation by Plk1 triggers the dissociation of cohesin from chromosome arms (Sumara et al., 2002
; Losada et al., 2002
; Hauf et al., 2005
). By contrast, centromeric cohesin is cleaved by separase specifically at the onset of anaphase (Gimenez-Abian et al., 2004
; Hauf et al., 2001
). Centromeric chromosome cohesion is protected from proteolysis before anaphase by Sgo1 (Kitajima et al., 2005
; McGuinness et al., 2005
). The centromeric localization of Sgo1 is regulated by Bub1 kinase and PP2A phosphatase (Kitajima et al., 2005
; Tang et al., 2006
). The cleavage of centromeric cohesin and initiation of sister chromatid separation is controlled by the spindle checkpoint. The spindle checkpoint monitors both the interactions between kinetochores and spindle microtubules and the tension across paired kinetochores, and it delays cohesin cleavage and anaphase onset until all chromosomes are properly attached to the spindle and aligned at the metaphase plate (Lew and Burke, 2003
; Musacchio and Hardwick, 2002
). Spindle checkpoint function involves protein phosphorylation and proteolysis (Cleveland et al., 2003
). Indeed, several of the checkpoint proteins including Msp1, Bub1 and BubR1 are protein kinases. In addition to the spindle checkpoint kinases, several other known kinases such as CDK1, aurora kinases and Plk1 play important regulatory roles in mitosis (Peters, 2002
; Tang et al., 2004a
; Acquaviva et al., 2004
; van Vugt et al., 2004
; Jackman et al., 2003
; Lampson et al., 2004
; Sumara et al., 2004
; Barr et al., 2004
; van Vugt and Medema, 2005
). These mitotic kinases also generate signals preventing the proteolysis of anaphase inhibitors and mitotic cyclins, thereby blocking the onset of anaphase (Peters, 2002
). Here we show that the CDK11p58 kinase also plays a crucial role in mitotic progression and is required for the maintenance of sister chromatid cohesion and for the completion of mitosis in human cells.
| Results |
|---|
|
|
|---|
, IFITM1) whose expression are induced by activation of the interferon response pathway, were also performed to ensure that the phenotype was not because of induction of interferon-mediated responses to dsRNA (data not shown).
|
CDK11 depletion causes G2/M cell-cycle block and subsequent cell death
In addition to the spindle and centrosome abnormalities, we also noticed an accumulation of rounded cells and an increase in cells with an apoptotic appearance after treatment with the siRNAs that most effectively targeted CDK11. The number of cells exhibiting these morphologies correlated with the severity of CDK11 depletion. For example, cells treated with siRNA A1361 had a near-normal appearance, whereas treatment with expression construct A2184 caused the appearance of numerous rounded and dying cells (Fig. 1B). DNA content analysis verified an increase in the cell population in G2/M phase of the cell cycle and in the population of sub-G1 CDK11 RNAi cells in the cultures with the severe phenotype (Fig. 1C). This sub-G1 population was stained by annexin V, indicating that these cells were apoptotic (data not shown). The mitotic arrest and subsequent cell death resulting from CDK11 depletion were also shown by time-lapse microscopy of HeLa and HeLa H2B-GFP cells 48 hours after transfection (see supplementary material Fig. S2 and Movies 1 and 2).
G2/M accumulation is because of mitotic arrest of cells containing prematurely separated sister chromatids
To clarify the composition of the enhanced G2/M population resulting from CDK11 depletion (Fig. 1), chromosome analysis was performed. No obvious differences in chromosome condensation were visible upon staining with DAPI or antibodies that detect phosphorylation of serine 10 of histone H3, a marker that correlates with chromosome condensation (Wei et al., 1999
) (data not shown). Interestingly, however, depletion of CDK11 with all of the constructs resulted in abnormalities in chromosome segregation. The extent of these abnormalities correlated with the level of CDK11 depletion. Moderate CDK11 depletion with the A1361 oligonucleotide and expression constructs did not prevent mitosis, although the cells exhibited an increase in the presence of misaligned and lagging chromosomes (Fig. 2A,B). By contrast, more complete depletion dramatically increased the population of cells with condensed chromosomes and slightly separated sister chromatids whereas mitotic cells with a typical anaphase or telophase appearance were absent (Fig. 2C,D). In addition, very few cells were observed with all chromosomes aligned on the metaphase plate. Rather, most cells exhibited incomplete chromosome congression. Expression of the pSUPER-A2184 (CDK11 RNAi-C) resulted in the strongest phenotype, which correlated directly with the level of CDK11 depletion (Fig. 1A). Of the total mitotic cells treated with the A2184 construct, 62% exhibited premature sister chromatid separation after CDK11 depletion, although most of the separated sister chromatids remained paired (Fig. 2C,D). This observation was confirmed by measuring the inter-kinetochore distances of 50-100 paired sister chromatids stained with CREST antibody at different points during G2/M. The interkinetochore distance between the sister chromatids of the control and CDK11 RNAi cells was identical in G2 (control 0.46±0.06 µm and CDK11 RNAi cells 0.43±0.08 µm) and in prophase (control 0.61±0.1 µm and CDK11 RNAi cells 0.61±0.04 µm). However, the distance between the kinetochores was significantly larger at later stages in mitosis. The distance between the sister chromatids of the postprophase-arrested CDK11 RNAi cells was 1.05±0.24 µm, whereas the average distance of the control cells at a comparable stage in mitosis was only 0.76±0.15 µm. In fact, the distance between the sister chromatids in CDK11 RNAi cells was larger than that of metaphase control cells (1.05±0.24 µm versus 0.89±0.14 µm). Importantly, overexpression of the RNAi-resistant form of CDK11p58-GFP, but not the RNAi-sensitive form, reduced the number of cells with prematurely separated sister chromatids by
75% (Fig. 3).
|
|
Depletion of CDK11 results in prometaphase-metaphase cell cycle arrest
To probe the nature of the mitotic arrest, we analyzed the response of CDK11-depleted cells to the microtubule poisons nocodazole and taxol. These agents trigger the spindle checkpoint, resulting in a prometaphase-metaphase mitotic arrest. As expected, the percentage of prometaphase-metaphase cells increased in control cultures during a six-hour exposure to these agents. By contrast, the number of prometaphase-metaphase CDK11 RNAi cells did not increase in response to either treatment, although there was a slight increase in the population of cells with prematurely separated sister chromatids in response to treatment with the microtubule-stabilizing drug taxol (Fig. 2D), suggesting that the spindle checkpoint can delay sister chromatid separation in the presence of tension or that sister chromatid tension per se plays a role in the retention of cohesion complexes.
As an additional means to determine the nature of the mitotic arrest in the CDK11-depleted cells, we performed immunofluorescence staining with antibodies to cyclins A and B1. Both of these cyclins are required for mitotic progression, although cyclin A is degraded during the prometaphase-metaphase transition, whereas cyclin B1 is degraded during the metaphase-anaphase transition (Lew and Kornbluth, 1996
; Peters, 2002
). Immunofluorescence staining of cyclins A and B1 in CDK11 RNAi cells revealed that most of the mitotic cells lacked detectable cyclin A but retained cyclin B1 (Fig. 4A). These findings support the conclusion that CDK11 depletion results in premature sister chromatid separation and mitotic arrest at the prometaphase-metaphase transition.
|
CDK11 is required for maintenance of chromosome cohesion during mitosis
The premature separation of the sister chromatids suggested that diminished CDK11 results in defects in maintenance of cohesion and/or premature removal of cohesin complexes.
To investigate the effects of CDK11 on sister chromatid cohesion in more detail, we transfected HeLa cells expressing the Myc-tagged human Scc1 cohesin component with CDK11 RNAi constructs and monitored Scc1 by immunofluorescence. Our data indicated that the cohesin complexes were present on the chromosomes and kinetochores of CDK11-depleted cells at the early stage of mitosis; however, Scc1 was prematurely removed from post-prophase mitotic cells (Fig. 5). In fact, 64% of the CDK11-depleted mitotic cells were Myc-Scc1 negative, whereas only 25% of the control RNAi cells were Myc-Scc1 negative (Fig. 5) (McGuinness et al., 2005
). The percentage of CDK11 RNAi cells exhibiting a premature loss of cohesion did not change in response to nocodazole treatment, suggesting that CDK11 plays a role in protecting and/or maintaining cohesion complexes prior to the metaphase.
|
|
|
| Discussion |
|---|
|
|
|---|
The presence of prematurely separated sister chromatids after downregulation of CDK11p58 suggests that the kinase plays a role in maintenance or protection of chromosome cohesion. To test this possibility, we examined the effects of simultaneous depletion of CDK11 and two proteins with known roles in chromosome cohesion, Plk1 and Sgo1. Codepletion of CDK11 and Sgo1 increased the extent of the sister chromatid separation beyond that caused by the depletion of CDK11 alone. Depletion of Plk1 alone resulted in mitotic cells with hypercondensed chromosomes with closed arms. When the loss of Plk1 was combined with the loss of CDK11, the chromosomes remained hypercondensed, but the chromatids were separated. These findings support a role for CDK11 in the maintenance of chromosome cohesion but not in chromosome condensation. A similar phenotype has also been observed upon codepletion of Sgo1 and Plk1 (McGuinness et al., 2005
). The similarities in the codepletion phenotype suggest that CDK11, like Sgo1, is required for maintenance of both centromere and arm cohesion and that CDK11 and Sgo1 function in the same or redundant pathways. This theory is supported by the similar appearance of chromosomes from Sgo1 and CDK11 RNAi cells and by the alterations in the localization of Sgo1 in CDK11-depleted cells. This hypothesis is also supported by other similarities in the phenotypes of CDK11 and Sgo1 RNAi cells. RNAi-mediated depletion of Sgo1 causes premature centromeric sister chromatid separation and a permanent mitotic arrest comparable to that observed in CDK11 RNAi cells (Tang et al., 2004b
; Salic et al., 2004
; McGuinness et al., 2005
; Kitajima et al., 2005
). In addition, both CDK11- and Sgo1-depleted cells retain cyclin B expression (McGuinness et al., 2005
). Sister chromatid separation in Sgo1 RNAi cells does not appear to be mediated by separase but rather occurs through another mechanism, possibly involving phosphorylation of cohesin subunits (Tang et al., 2004b
; McGuinness et al., 2005
). Our analysis of CDK11-depleted cells suggests that removal of cohesin complexes from CDK11 and Sgo1 RNAi cells may occur through similar mechanisms, because CDK11 RNAi cells have high levels of cyclin B and a premature loss of Scc1 without a significant increase in Scc1 cleavage (data not shown). Thus, it is possible that CDK11 may function coordinately with Sgo1. Alternatively, CDK11 may be required for proper localization, binding or function of Sgo1 and Bub1 or PP2A; because these two other proteins are required for proper Sgo1 localization and function and for centromeric cohesion (Tang et al., 2004b
; Tang et al., 2006
). The observation that centromeric Bub1 is not properly retained at the centromere in post-prophase CDK11 RNAi cells is consistent with this possibility. The localization of PP2A has been reported to be Bub1-dependent and proper localization of Sgo1 is also dependent on PP2A (Tang et al., 2006
), thus the diminished binding of Bub1 in the CDK11 cells might explain the abnormal localization of Sgo1. A model depicting the role of CDK11 in chromosome cohesion is shown in Fig. 8. In this model, the effects of CDK11 on chromosome cohesion could result from direct interactions between CDK11 and Sgo1, Bub1 or PP2A. Alternatively, we propose that these interactions are transient and/or CDK11 phosphorylates one or more of these proteins prior to their localization at the kinetochore. We currently favor the second proposition because we have not been able to detect either interaction between CDK11 and the Sgo1 complex or kinetochore-associated CDK11. Although this may be because of technical problems with antibody recognition or CDK11 accessibility, these data indicate that further studies are needed to address the exact role of CDK11 in the maintenance of sister chromatid cohesion.
|
Although the spindle checkpoint in CDK11-depleted cells appears to be intact as these cells arrest in mitosis, it is not clear whether the loss of sister chromatid cohesion occurs before or after mitotic arrest. Cohesion defects because of premature dissociation of cohesion complexes caused by the loss of CDK11 could lead to checkpoint activation and cell cycle arrest. This model is consistent with recent data from studies with Xenopus demonstrating that antibody-mediated depletion of cohesin causes defects in chromosome congression, spindle abnormalities, changes in kinetochore structure, and aberrant kinetochore attachment and chromosome movement that trigger the spindle checkpoint (Kenney and Heald, 2006
). Alternatively, dissociation of sister chromatid cohesion could occur after mitotic progression was halted by the spindle checkpoint. In this scenario, induction of the spindle checkpoint could result from defects in spindle-kinetochore attachment, faulty spindle structure, and/or improper function of the spindle checkpoint because of aberrant phosphorylation resulting from the loss of CDK11. The absence of CDK11 would compromise the ability of Sgo1 to protect the arrested cells from a loss of centromeric cohesion and premature sister chromatid separation. Importantly, the inability to override the spindle checkpoint and proceed through mitosis in either model could result from a combination of spindle checkpoint activity, aberrations in the structure of the mitotic spindle, defects in kinetochore attachment, and/or a requirement for CDK11 kinase activity for the completion of anaphase.
The data from this study demonstrates that CDK11p58 is required for mitotic progression. The severe depletion data imply that complete loss of CDK11 in vivo would prevent mitotic progression and would be lethal to cells and to survival of an organism. The observation that CDK11-null embryos die immediately after depletion of maternal CDK11 protein stores (Li et al., 2004
) is consistent with this prediction. Importantly, CDK11-null embryos have an increased percentage of mitotic and apoptotic cells, suggesting that loss of CDK11 results in a mitotic arrest followed by apoptotic death similar to that observed in severely depleted CDK11 RNAi cells. By contrast, HeLa cells treated with hypomorphic siRNA constructs, which caused only partial loss of CDK11 protein, completed mitosis despite the presence of spindle defects and lagging chromosomes. These data suggest that loss of a single CDK11 allele because of deletion of chromosome 1p36, which is frequently observed in tumors such as neuroblastoma, melanoma, breast cancer and several types of leukemia and lymphoma (Brodeur et al., 1977
; Poetsch et al., 2003
; Mori et al., 2003
; Melendez et al., 2003
; Bieche et al., 1993
), could increase the number of aneuploid cells, thereby contributing to tumorigenesis. This conclusion is supported by recent studies examining the responses of CDK11 haploinsufficient mice to carcinogens known to cause skin cancer (Chandramouli et al., 2007
). Mice with a single functional CDK11 allele exhibited an increase in tumor size and number in this skin cancer model system (Chandramouli et al., 2007
). Importantly, however, the rate of tumor formation was not increased in this model system nor have we observed any increase in the frequency of spontaneous tumors in our CDK11 heterozygous mice, suggesting that other cooperating genetic events are required for tumor formation and progression.
The plethora of mitotic effects observed in CDK11 RNAi cells probably results from alteration of phosphorylation of CDK11 substrates. Recently, WAPL (Kueng et al., 2006
; Gandhi et al., 2006
), Haspin (Dai et al., 2006
) and PICH (Baumann et al., 2007
) have been found to play roles in chromosome cohesion. It will be of interest to determine whether any of these proteins are phosphorylated directly by CDK11p58. However, it is very likely that many of the mitotic abnormalities we have identified in this study are indirect and arise from defective kinase cascades. The observation that CDK11 RNAi expression decreased Plk1 localization at the centromere (Petretti et al., 2006
) strongly supports this conclusion. Indeed, multiple kinase cascades involving kinases that regulate CDK11 or are regulated by CDK11, such as BubR1, Mps1, Plk1, aurora, CDK1, MAPK and others, are likely to exist. In addition, the CDK11p58 amino acid sequence has strong homology to CDK1 and possesses all of the sites and motifs that regulate the mitotic activity of CDK1 (Trembley et al., 2004
), suggesting the mitotic kinase activity of CDK11 might be regulated by posttranslational modifications. It remains to be determined whether modification of these sites regulates the activity of CDK11. Nonetheless, the collection of mitotic abnormalities resulting from CDK11 depletion clearly establishes a role for CDK11 as a mitotic kinase.
| Materials and Methods |
|---|
|
|
|---|
-tubulin (Sigma),
-tubulin (Cell Skeleton), anti-Myc monoclonal antibody (mAb) (Upstate-Millipore), Bub1 (Chemicon International), Sgo1 (kindly provided by H. Yu, University of Texas Southwestern Medical Center, Dallas) and actin (Santa Cruz). Secondary antibodies included anti-mouse IgG-Texas Red (Amersham Biosciences), anti-rabbit IgG-FITC (Amersham Biosciences), anti-mouse IgG-Cy3 (Jackson ImmunoResearch), anti-rabbit IgG-Cy3 (Jackson ImmunoResearch) and anti-human IgG-FITC (Pierce). For studies using microtubule toxin treatment to examine the spindle checkpoint, nocodazole (0.1 µg/ml) or taxol (33 nM) were added to the culture media, and the cells were harvested at the indicated times for further analysis.
CDK11 RNAi
The pSUPER siRNA expression vector (Brummelkamp et al., 2002
), kindly provided by Reuven Agami (Netherlands Cancer Institute, Amsterdam), was used for construction of CDK11 RNAi constructs containing 19-nucleotide sequences designed to target various regions of CDK11, as previously described (Brummelkamp et al., 2002
). The 19-nucleotide CDK11-targeting sequences were A461: 5'-GGGAGATGGCAAGGGAGCA-3' (CDK11 RNAi-N); A2184: 5'-GAGCGAGCAGCAGCGTGTG-3' (CDK11 RNAi-C); A910: 5'-GGGAGCACCAGTGAAGAAT-3'; A111: 5'-TTCTGATGACCGGGATTCC-3'; A188: 5'-GGAACTCCCCGTATAGAAG-3'; and A1361: 5'-AGCGGCTGAAGATGGAGAA-3'. For electroporation delivery of pSUPER RNAi constructs, cells were grown to
85% confluence, harvested, and suspended at a density of approximately 107 cells/ml. Cells (400 µl of the suspension) were then added to a 4-mm electroporation cuvette (BioRad), along with 25 µg of plasmid DNA. Electroporation was performed using an Electro Cell Manipulator (BTX ECM 630, BTX Instruments) at 220 V and 960 µF capacitance. After electroporation, cells were transferred to plates with complete DMEM for cultivation. Apoptosis and cell-cycle analysis of the CDK11 RNAi-treated cells were examined by annexin V staining and flow cytometry, respectively. Immunobloting with cell lysates prepared from CDK11 RNAi-treated cells and control cells was performed with the indicated antibodies used as described throughout this study. The pSUPER Plk1 and Sgo1 siRNA expression constructs were constructed similarly using the following oligonucleotides: Sgo1, 5'-CAGUAGAACCUGCUCAGAA-3'; and Plk1, 5'-CGAGCUGCUUAAUGACGAG-3') (McGuinness et al., 2005
). The A1361 CDK11 siRNA was synthesized from Dharmacon and transfected into HeLa cells using 4 µl of Dharmafect1 and 50 nM siRNA oligonucleotides in each well of a six-well dish according to the manufacturer's instructions (Dharmacon).
CDK11p58-GFP cell lines
The plasmids used for generation of stable HeLa tranfectants were constructed by cloning the CDK11p58 cDNA or a CDK11p58 cDNA with a silent mutation in the CDK11 RNAi targeting region (the mutated CDK11 siRNA targeting sequence: 5'-AAGTGAACAACAGCGTGTG-3') into pEGFP-N3 vector, whose CMV promoter was replaced with an SV40 promoter taken from a pSVL plasmid by PCR to yield a C-terminal p58-GFP fusion protein. The resulting plasmids were transfected into HeLa cells, and single cells were cloned under neomycin selection and GFP sorting.
Immunofluorescence analysis
HeLa cells, cultured on coverslips for 48 hours after being transfected with RNAi constructs with or without microtubule toxin treatment, were fixed for 10 minutes with 4% formaldehyde and permeabilized for 3 minutes with 0.3% Triton X-100/phosphate-buffered saline (PBS) and then blocked with 10% fetal bovine serum (FBS) for 30 minutes followed by incubation with various primary antibodies for 1 hour at 37°C. The coverslips were then washed and incubated with the fluorchrome-conjugated secondary antibodies for 1 hour at 37°C, washed with PBS and mounted with Vectashield mounting medium containing 0.05 µg/ml DAPI. Samples were analyzed either on a Nikon C1si Eclipse TE2000-E using a 60x objective (NA 1.45) with images acquired using EZ C1 software or on a Nikon Eclipse E-80i using a 100x objective (NA 1.35) with images acquired with a DS-SM-L digital camera using the Nikon DS-L1 software. TIFF image files were further manipulated using Adobe Photoshop 7.0.
FISH analysis
FISH analysis was performed as described previously (Gururajan et al., 1998
) with a BAC clone containing the human histone cluster located at 6p21 (RPCI-11-300H3) and a plasmid containing human chromosome 1 heterochromatin repeats (pUC 1.77). Specific hybridization signals were detected with anti-digoxigenin FITC (Roche Biochemicals) followed by counter-staining with DAPI. The distance between sister chromatids of 25 G2 cells from each RNAi-treated group was determined by measuring the distance between paired FISH signals from the same cell for multiple sets of signals; 25 independent G2 cell measurements were made for each G2-synchronized RNAi group from photomicrographs.
Mitotic chromosome analysis and mitotic index analysis
Cells transfected with RNAi constructs were harvested with trypsin and subjected to a hypotonic treatment for chromosome mitotic spread and Giemsa staining. For each sample, a mitotic index was determined by dividing the number of mitotic cells by the total number of cells examined in a sample. More than 1000 cells were counted in each experiment and the experiments were performed multiple times with similar data. Chromosome appearance and occurrence frequency were determined by analyzing more than 100 mitotic cells for each RNAi condition in a single experiment.
| Acknowledgments |
|---|
| Footnotes |
|---|
| References |
|---|
|
|
|---|
Acquaviva, C., Herzog, F., Kraft, C. and Pines, J. (2004). The anaphase promoting complex/cyclosome is recruited to centromeres by the spindle assembly checkpoint. Nat. Cell Biol. 6, 892-898.[CrossRef][Medline]
Barr, F. A., Sillje, H. H. and Nigg, E. A. (2004). Polo-like kinases and the orchestration of cell division. Nat. Rev. Mol. Cell Biol. 5, 429-440.[CrossRef][Medline]
Baumann, C., Hofmann, K. and Nigg, E. A. (2007). PICH, a centromere-associated SNF2 family ATPase, is regulated by Plk1 and required for the spindle checkpoint. Cell 128, 101-114.[CrossRef][Medline]
Bieche, I., Champeme, M.-H., Matifas, F., Cropp, C. S., Callahan, R. and Lidereau, R. (1993). Two distinct regions involved in 1p deletion in human primary breast cancer. Cancer Res. 53, 1990-1994.
Blagosklonny, M. V. (2007). Mitotic arrest and cell fate: why and how mitotic inhibition of transcription drives mutually exclusive events. Cell Cycle 6, 70-74.[Medline]
Brodeur, G. M., Sekhon, G. and Goldstein, M. N. (1977). Chromosomal aberrations in human neuroblastomas. Cancer 40, 2256-2263.[CrossRef][Medline]
Brummelkamp, T. R., Bernards, R. and Agami, R. (2002). A system for stable expression of short interfering RNAs in mammalian cells. Science 296, 550-553.
Bunnell, B. A., Heath, L. S., Adams, D. E., Lahti, J. M. and Kidd, V. J. (1990). Increased expression of a 58-kDa protein kinase leads to changes in the CHO cell cycle. Proc. Natl. Acad. Sci. USA 87, 7467-7471.
Castedo, M., Perfettini, J. L., Roumier, T., Andreau, K., Medema, R. and Kroemer, G. (2004). Cell death by mitotic catastrophe: a molecular definition. Oncogene 23, 2825-2837.[CrossRef][Medline]
Chandramouli, A., Shi, J., Feng, Y., Holubec, H., Shanas, R., Bhattacharyya, A. K., Zheng, W. and Nelson, M. A. (2007). Haploinsufficiency of the cdc2l gene contributes to skin cancer development in mice. Carcinogenesis doi: 10.1093/carcin/bgm066.
Chen, H. H., Wang, Y. C. and Fann, M. J. (2006). Identification and characterization of the CDK12/cyclin L1 complex involved in alternative splicing regulation. Mol. Cell. Biol. 26, 2736-2745.
Chen, R. H. (2002). BubR1 is essential for kinetochore localization of other spindle checkpoint proteins and its phosphorylation requires Mad1. J. Cell Biol. 158, 487-496.
Cleveland, D. W., Mao, Y. and Sullivan, K. F. (2003). Centromeres and kinetochores: from epigenetics to mitotic checkpoint signaling. Cell 112, 407-421.[CrossRef][Medline]
Cornelis, S., Bruynooghe, Y., Denecker, G., Van Huffel, S., Tinton, S. and Beyaert, R. (2000). Identification and characterization of a novel cell cycle-regulated internal ribosome entry site. Mol. Cell 5, 597-605.[CrossRef][Medline]
Dai, J., Sullivan, B. A. and Higgins, J. M. (2006). Regulation of mitotic chromosome cohesion by Haspin and Aurora B. Dev. Cell 11, 741-750.[CrossRef][Medline]
Gandhi, R., Gillespie, P. J. and Hirano, T. (2006). Human Wapl is a cohesin-binding protein that promotes sister-chromatid resolution in mitotic prophase. Curr. Biol. 16, 2406-2417.[CrossRef][Medline]
Gimenez-Abian, J. F., Sumara, I., Hirota, T., Hauf, S., Gerlich, D., de la Torre, C., Ellenberg, J. and Peters, J. M. (2004). Regulation of sister chromatid cohesion between chromosome arms. Curr. Biol. 14, 1187-1193.[CrossRef][Medline]
Gururajan, R., Lahti, J. M., Grenet, J., Easton, J., Gruber, I., Ambros, P. F. and Kidd, V. J. (1998). Duplication of a genomic region containing the Cdc2L1-2 and MMP21-22 genes on human chromosome 1p36.3 and their linkage to D1Z2. Genome Res. 8, 929-939.
Harper, J. W. and Adams, P. D. (2001). Cyclin-dependent kinases. Chem. Rev. 101, 2511-2526.[CrossRef][Medline]
Hauf, S., Waizenegger, I. C. and Peters, J. M. (2001). Cohesin cleavage by separase required for anaphase and cytokinesis in human cells. Science 293, 1320-1323.
Hauf, S., Roitinger, E., Koch, B., Dittrich, C. M., Mechtler, K. and Peters, J. M. (2005). Dissociation of cohesin from chromosome arms and loss of arm cohesion during early mitosis depends on phosphorylation of SA2. PLoS Biol. 3, e69.[CrossRef][Medline]
Hu, D., Mayeda, A., Trembley, J. H., Lahti, J. M. and Kidd, V. J. (2003). CDK11 complexes promote pre-mRNA splicing. J. Biol. Chem. 278, 8623-8629.
Kenney, R. D. and Heald, R. (2006). Essential roles for cohesin in kinetochore and spindle function in Xenopus egg extracts. J. Cell Sci. 119, 5057-5066.
Kitajima, T. S., Hauf, S., Ohsugi, M., Yamamoto, T. and Watanabe, Y. (2005). Human Bub1 defines the persistent cohesion site along the mitotic chromosome by affecting Shugoshin localization. Curr. Biol. 15, 353-359.[CrossRef][Medline]
Kueng, S., Hegemann, B., Peters, B. H., Lipp, J. J., Schleiffer, A., Mechtler, K. and Peters, J. M. (2006). Wapl controls the dynamic association of cohesin with chromatin. Cell 127, 955-967.[CrossRef][Medline]
Jackman, M., Lindon, C., Nigg, E. A. and Pines, J. (2003). Active cyclin B1-Cdk1 first appears on centrosomes in prophase. Nat. Cell Biol. 5, 143-148.[CrossRef][Medline]
Lahti, J. M., Xiang, J., Heath, L. S., Campana, D. and Kidd, V. J. (1995). PITSLRE protein kinase activity is associated with apoptosis. Mol. Cell. Biol. 15, 1-11.[Abstract]
Lampson, M. A. and Kapoor, T. M. (2005). The human mitotic checkpoint protein BubR1 regulates chromosome-spindle attachments. Nat. Cell Biol. 7, 93-98.[CrossRef][Medline]
Lampson, M. A., Renduchitala, K., Khodjakov, A. and Kapoor, T. M. (2004). Correcting improper chromosome-spindle attachments during cell division. Nat. Cell Biol. 6, 232-237.[Medline]
Lew, D. J. and Kornbluth, S. (1996). Regulatory roles of cyclin dependent kinase phosphorylation in cell cycle control. Curr. Opin. Cell Biol. 8, 795-804.[CrossRef][Medline]
Lew, D. J. and Burke, D. J. (2003). The spindle assembly and spindle position checkpoints. Annu. Rev. Genet. 37, 251-282.[CrossRef][Medline]
Li, T., Inoue, A., Lahti, J. M. and Kidd, V. J. (2004). Failure to proliferate and mitotic arrest of CDK11p110/p58-null mutant mice at the blastocyst stage of embryonic cell development. Mol. Cell. Biol. 24, 3188-3197.
Losada, A., Hirano, M. and Hirano, T. (2002). Cohesin release is required for sister chromatid resolution, but not for condensin-mediated compaction, at the onset of mitosis. Genes Dev. 16, 3004-3016.
McGuinness, B. E., Hirota, T., Kudo, N. R., Peters, J. M. and Nasmyth, K. (2005). Shugoshin prevents dissociation of cohesin from centromeres during mitosis in vertebrate cells. PLoS Biol. 3, e86.[CrossRef][Medline]
Melendez, B., Cuadros, M., Robledo, M., Rivas, C., Fernandez-Piqueras, J., Martinez-Delgado, B. and Benitez, J. (2003). Coincidental LOH regions in mouse and humans: evidence for novel tumor suppressor loci at 9q22-q34 in non-Hodgkin's lymphomas. Leuk. Res. 27, 627-633.[CrossRef][Medline]
Meraldi, P., Draviam, V. M. and Sorger, P. K. (2004). Timing and checkpoints in the regulation of mitotic progression. Dev. Cell 7, 45-60.[CrossRef][Medline]
Mori, N., Morosetti, R., Mizoguchi, H. and Koeffler, H. P. (2003). Progression of myelodysplastic syndrome: allelic loss on chromosomal arm 1p. Br. J. Haematol. 122, 226-230.[CrossRef][Medline]
Musacchio, A. and Hardwick, K. G. (2002). The spindle checkpoint: structural insights into dynamic signalling. Nat. Rev. Mol. Cell Biol. 3, 731-741.[CrossRef][Medline]
Nicklas, R. B., Ward, S. C. and Gorbsky, G. J. (1995). Kinetochore chemistry is sensitive to tension and may link mitotic forces to a cell cycle checkpoint. J. Cell Biol. 130, 929-939.
Peters, J. M. (2002). The anaphase-promoting complex: proteolysis in mitosis and beyond. Mol. Cell 9, 931-943.[CrossRef][Medline]
Petretti, C., Savoian, M., Montembault, E., Glover, D. M., Prigent, C. and Giet, R. (2006). The PITSLRE/CDK11p58 protein kinase promotes centrosome maturation and bipolar spindle formation. EMBO Rep. 7, 418-424.[Medline]
Poetsch, M., Dittberner, T. and Woenckhaus, C. (2003). Microsatellite analysis at 1p36.3 in malignant melanoma of the skin: fine mapping in search of a possible tumour suppressor gene region. Melanoma Res. 13, 29-33.[CrossRef][Medline]
Salic, A., Waters, J. C. and Mitchison, T. J. (2004). Vertebrate Shugoshin links sister centromere cohesion and kinetochore microtubule stability in mitosis. Cell 118, 567-578.[CrossRef][Medline]
Sumara, I., Vorlaufer, E., Stukenberg, P. T., Kelm, O., Redemann, N., Nigg, E. A. and Peters, J. M. (2002). The dissociation of cohesin from chromosomes in prophase is regulated by Polo-like kinase. Mol. Cell. 9, 515-525.[CrossRef][Medline]
Sumara, I., Gimenez-Abian, J. F., Gerlich, D., Hirota, T., Kraft, C., de la Torre, C., Ellenberg, J. and Peters, J. M. (2004). Roles of polo-like kinase 1 in the assembly of functional mitotic spindles. Curr. Biol. 14, 1712-1722.[CrossRef][Medline]
Tang, Z., Bharadwaj, R., Li, B. and Yu, H. (2001). Mad2-Independent inhibition of APCCdc20 by the mitotic checkpoint protein BubR1. Dev. Cell 1, 227-237.[CrossRef][Medline]
Tang, Z., Shu, H., Oncel, D., Chen, S. and Yu, H. (2004a). Phosphorylation of Cdc20 by Bub1 provides a catalytic mechanism for APC/C inhibition by the spindle checkpoint. Mol. Cell 16, 387-397.[CrossRef][Medline]
Tang, Z., Sun, Y., Harley, S. E., Zou, H. and Yu, H. (2004b). Human Bub1 protects centromeric sister-chromatid cohesion through Shugoshin during mitosis. Proc. Natl. Acad. Sci. USA 101, 18012-18017.
Tang, Z., Shu, H., Qi, W., Mahmood, N. A., Mumby, M. C. and Yu, H. (2006). PP2A is required for centromeric localization of Sgo1 and proper chromosome segregation. Dev. Cell 10, 575-585.[CrossRef][Medline]
Tinton, S. A., Schepens, B., Bruynooghe, Y., Beyaert, R. and Cornelis, S. (2005). Regulation of the cell-cycle-dependent internal ribosome entry site of the PITSLRE protein kinase: roles of Unr (upstream of N-ras) protein and phosphorylated translation initiation factor eIF-2alpha. Biochem. J. 385, 155-163.[CrossRef][Medline]
Trembley, J. H., Hu, D., Hsu, L. C., Yeung, C. Y., Slaughter, C., Lahti, J. M. and Kidd, V. J. (2002). PITSLRE p110 protein kinases associate with transcription complexes and affect their activity. J. Biol. Chem. 277, 2589-2596.
Trembley, J. H., Hu, D., Slaughter, C. A., Lahti, J. M. and Kidd, V. J. (2003). Casein kinase 2 interacts with cyclin-dependent kinase 11 (CDK11) in vivo and phosphorylates both the RNA polymerase II carboxyl-terminal domain and CDK11 in vitro. J. Biol. Chem. 278, 2265-2270.
Trembley, J. H., Loyer, P., Hu, D., Li, T., Grenet, J., Lahti, J. M. and Kidd, V. J. (2004). Cyclin dependent kinase 11 in RNA transcription and splicing. Prog. Nucleic Acid Res. Mol. Biol. 77, 263-288.[Medline]
van Vugt, M. A. and Medema, R. H. (2005). Getting in and out of mitosis with Polo-like kinase-1. Oncogene 24, 2844-2859.[CrossRef][Medline]
van Vugt, M. A., van de Weerdt, B. C., Vader, G., Janssen, H., Calafat, J., Klompmaker, R., Wolthuis, R. M. and Medema, R. H. (2004). Polo-like kinase-1 is required for bipolar spindle formation but is dispensable for anaphase promoting complex/Cdc20 activation and initiation of cytokinesis. J. Biol. Chem. 279, 36841-36854.
Watanabe, Y. and Kitajima, T. S. (2005). Shugoshin protects cohesin complexes at centromeres. Philos. Trans. R. Soc. Lond. B Biol. Sci. 360, 515-521.[CrossRef]
Wei, Y., Yu, L., Bowen, J., Gorovsky, M. A. and Allis, C. D. (1999). Phosphorylation of histone H3 is required for proper chromosome condensation and segregation. Cell 97, 99-109.[CrossRef][Medline]
Wilker, E. W., van Vugt, M. A., Artim, S. A., Huang, P. H., Petersen, C. P., Reinhardt, H. C., Feng, Y., Sharp, P. A., Sonenberg, N., White, F. M. et al. (2007). 14-3-3sigma controls mitotic translation to facilitate cytokinesis. Nature 446, 329-332.[CrossRef][Medline]
This article has been cited by other articles:
![]() |
J.-M. Peters, A. Tedeschi, and J. Schmitz The cohesin complex and its roles in chromosome biology Genes & Dev., November 15, 2008; 22(22): 3089 - 3114. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Evangelista, T. Y. Lim, J. Lee, L. Parker, A. Ashique, A. S. Peterson, W. Ye, D. P. Davis, and F. J. de Sauvage Kinome siRNA Screen Identifies Regulators of Ciliogenesis and Hedgehog Signal Transduction Sci. Signal., September 30, 2008; 1(39): ra7 - ra7. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Loyer, J. H. Trembley, J. A. Grenet, A. Busson, A. Corlu, W. Zhao, M. Kocak, V. J. Kidd, and J. M. Lahti Characterization of Cyclin L1 and L2 Interactions with CDK11 and Splicing Factors: INFLUENCE OF CYCLIN L ISOFORMS ON SPLICE SITE SELECTION J. Biol. Chem., March 21, 2008; 283(12): 7721 - 7732. [Abstract] [Full Text] [PDF]< |